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Introduction: Chronic hepatitis C virus infection patients have higher rates of psychiatric
disorders  than the general population. Chronic hepatitis C virus infection is known to
be  associated with impaired health related quality of life. To our knowledge, there is no
previous  research of health related quality of life in chronic hepatitis C patients that com-
bined  structured psychiatric interview and careful psychopathological evaluation, including
depression,  anxiety and fatigue instruments. The aim of this study was to evaluate health
related  quality of life of chronic hepatitis C patients and to investigate the association with
sociodemographic,  psychopathological and psychiatric factors.
Materials  and methods: Eighty-one individuals with chronic hepatitis C virus infection receiv-
ing  care at a Brazilian public university-based outpatient service for infectious diseases
were  enrolled in the study. The World Health Organization Quality of Life Scale Brief Ver-
sion  was used to assess health related quality of life. Standard psychiatric interview (Mini
International  Neuropsychiatric Interview-Plus) was conducted to establish Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition, Axis I psychiatric diagnosis. Fur-
ther  instruments completed psychopathological investigation: Beck Depression Inventory,
Hospital  Anxiety and Depression Scale, Brief Fatigue Inventory, Hamilton Depression Scale
and  Hamilton Anxiety Scale. Pearson Chi-Square and Kruskal–Wallis were  performed for
categorical  and continuous univariate analysis, respectively. Correlation between psycho-pathological  and health related quality of life scores was performed according to Spearman’s
correlation.  Multivariate analysis was performed according to stepwise forward ordinal
he signiﬁcance threshold was ﬁxed at  ˛ = 0.05.logistic  regression. TResults: Depressive disorders were associated with worse scores in overall health related
quality  of life and in all domains. Fatigue was associated with lower scores in physical
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and psychological domains, and married status with higher scores in psychological health
related quality of life. We  found strong correlation among scores of depression, fatigue and
health related quality of life.
Conclusion: Depression and fatigue must be properly investigated and managed in HCV
patients in order to improve HRQL. WHOQOL-BREF proved to be a useful instrument to
assess HRQL in HCV patients.
13 EIntroduction
Chronic hepatitis C virus (HCV) infection is a major health
problem with around 160 million people infected worldwide.1
HCV leads to cirrhosis in up to 20% of those chron-
ically infected and is the primary indication for liver
transplantation.2 This burden is multiplied by the impact
of  HCV on health related quality of life (HRQL). Common
complaints are fatigue, musculoskeletal pain, depression and
perceived  inability to function effectively.3,4 HCV itself may
diminish  HRQL even in the absence of advanced liver disease,
perhaps  as a result of extrahepatic symptoms related to HCV,
cognitive  dysfunction or psychosocial implications.5
Previous studies have implicated psychiatric disorders,
especially depression, as contributing factor impairing qual-
ity  of life of HCV patients.6 Nevertheless most studies on
HRQL  in HCV did not perform structured clinical interview
in  order to establish Diagnostic and Statistical Manual of
Mental  Disorders, Fourth Edition (DSM-IV) Axis I psychiatric
diagnosis.3,6,7 Psychiatric disorders are more  common in HCV
patients  than in the general population and may  constitute a
major cause of antiviral treatment interruption with negative
impact  on treatment response rates and prognosis.8 Fatigue
and  irritability are also common symptoms in HCV patients
and  may  impair HRQL.9
There is scarce literature on the World Health Organization
Quality of Life Scale Brief Version (WHOQOL-BREF) use in HCV
patients.3 The WHOQOL-BREF is found to be a high quality
patient-centered tool suited for individual assessment in clin-
ical  practice and research.10 One previous study showed good
correlation  among WHOQOL-BREF, Short Form-36 and Chronic
Liver  Disease Questionnaire in HCV patients.3 One recent work
determined  normative values for the WHOQOL-BREF in the
Brazilian  general population.11
The National Institutes of Health had recommended
studies that measure not only traditional biological out-
comes  in HCV (i.e., HCV RNA, liver enzyme levels, liver
histology), but also extrahepatic manifestations and patient-
oriented  outcomes.12 One recent review identiﬁed some
gaps  in the literature regarding assessment of symptoms
and  outcomes reported as important by HCV patients and
also  endorsed the importance of further research.13 The
study  of HRQL in HCV patients, including psychopathological
and psychiatric thorough evaluation, is in line with these
recommendations.
This  study aimed to evaluate HRQL of a Brazilian sample of
© 20HCV  patients and to investigate its association with sociode-
mographic, psychopathological and psychiatric factors using
structured  psychiatric interview and careful psychopatholo-
gical investigation.Materials  and  methods
Study  design,  setting  and  participants
Between May 2009 and November 2010, a cross sectional
study with a convenience sample of HCV patients were  per-
formed  at a public university-based outpatient service for
infectious  diseases (CTR-DIP Orestes Diniz-SMSA-BH/UFMG)
in Belo Horizonte, Minas Gerais, Brazil. Approximately 400
HCV  infected patients are currently under medical assistance
at  this service. All patients had more  than 18 years of age and
had  anti-HCV antibody positive by third-generation enzyme-
linked  immunosorbent assay for more  than six months and
HCV  RNA detectable by polymerase chain reaction (AMPLICOR,
Roche  Molecular Systems). Patients were excluded if they had
any  of the following: co-infection with hepatitis B virus or
HIV,  or low scores in the Mini Mental Status Examination14
suggestive of cognitive deﬁcit.
Procedures
All patients were  assessed on the same day of routine clinical
evaluation. Sociodemographic, clinical and laboratory data,
including  liver biopsy with Metavir score15 were  obtained
through chart review and patient interview. The presence
of  comorbid conditions was also assessed by chart review
and  categorized as hypertension, diabetes, or other. Cirrhosis
was  deﬁned according to documented liver biopsy, ultrasound
or  decompensated liver disease, deﬁned as a history of at
least  one of the following: ascites, jaundice, variceal bleed-
ing,  hepatic encephalopathy, hematemesis, palmar erythema,
gynecomastia.
Psychiatric  evaluation was  conducted by an experienced
psychiatrist who performed a structured clinical interview
using  the Mini International Neuropsychiatric Interview
(M.I.N.I.-Plus version).16 This instrument allows a psychiatric
diagnosis according to the Diagnostic and Statistical Man-
ual  of Mental Disorders, Fourth Edition (DSM-IV) and the
International Classiﬁcation of Diseases, 10th Revision Axis I
diagnostic criteria.
HRQL  was  measured by the WHOQOL-BREF, a generic HRQL
instrument  designed by the World Health Organization for
healthy  people and patients, used as an outcome measure
in  many  countries and cultures.10,17 It consists of 26 item
self-administered questionnaire based on the preceding two
lsevier Editora Ltda.Este é um artigo Open Access sob a licença de CC BY-NC-NDweeks.  WHOQOL-BREF interpretation considers four HRQL
domains,  namely, physical, psychological, social relationships
and  environment, besides overall health and quality of life per-
ception.  It has shown excellent psychometric and clinimetric
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Table 1 – Sociodemographic, clinical characteristics and
laboratory  data of 81 patients with chronic hepatitis C
virus  infection.
Characteristics n (%)
Sociodemographic
Age (years)a 50.6 ± 11.3
Gender (male) 43 (53.1)
Years of educationa 8.4 ± 4.7
Ethnicity (non-white) 44 (54.3)
Marital status (married) 43 (53.1)
Currently employed 35 (43.2)
Main  HCV transmission mode
Blood  transfusion 24 (29.6)
Intravenous drug use 18 (22.2)
Tattoo or piercing 14 (17.3)
Needle stick injury 3 (3.7)
Sex  3 (3.7)
Clinical and laboratory data
Years  since HCV diagnosisa 5.9 ± 4.4
Viral genotype 1 63 (77.8)
METAVIR A ≥ 2 35 (48.6)
METAVIR F ≥ 2 43 (59.7)
ALT  (IU/L)a 63.5 ± 65.4
Cirrhosis 6 (7.4)
Comorbidity 42 (51.9)
Hypertension 36 (44.4)
Diabetes 8 (9.9)
Other  comorbidities 16 (19.8)b r a z j i n f e c t d i s .
roperties, such as test–retest reliability, internal consistency,
iscriminant validity, and construct validity.18 This instru-
ent  had been previously translated into Portuguese and
alidated  for use in the Brazilian population.19
Depressive symptoms were  measured by three instru-
ents: Beck Depression Inventory (BDI), Hospital Anxiety and
epression  Rating Scale (HAD) and Hamilton Depression Rat-
ng Scale (HAM-D). BDI is a self-rating scale with 21 items,
ncluding somatic and non-somatic symptoms.20 It is the most
sed  self-rating depression scale, both in the clinical practice
nd  in research settings, and has proved to be the most efﬁ-
ient  inventory to screen for depression in HCV patients.21
Anxiety was  measured by the Hamilton Anxiety Rating
cale  (HAM-A)22 and the Hospital Anxiety and Depression Rat-
ng  Scale (HAD).23
Fatigue was  assessed through the Brief Fatigue Inventory
BFI),24 a self-administered scale used to measure severity of
atigue.  Average scores were  categorized, according to authors’
ecommendation, in mild (0–3 points), moderate (4–6 points),
r  severe fatigue (7–10 points). This instrument has proved
o  be useful in HCV patients, with concurrent validity when
ompared  to other instruments such as the Fatigue Impact
cale.5 A complementary analysis of fatigue was  performed
hrough its speciﬁc item on the BDI (item 17). Irritability was
nvestigated through another speciﬁc item of the BDI (item 11).
tatistical  analysis
RQL results were  analyzed by two distinct methods. In the
rst  one, a standardized conversion of Likert scale data pro-
ected  onto a 0–100 scale (to each domain and to overall health
nd  quality of life perception). This method is commonly used
n  the literature and provides results comparable to other
tudies.  Absolute scores were  also useful in order to inves-
igate  correlation among HRQL, depressive and fatigue scores.
 second method, used in the present study for all univariate
nd  multivariate analysis, consists of transforming the 0–100
cale  into an ordinal data according to interquartile ranges:
–25,  25–50, 50–75, 75–100. This method has been previously
tudied for HRQL instruments and may  be more  appropri-
te  to inferential process than statistical analyses that often
se  absolute scores with discrete, asymmetrical, and limited
istributions.25
Pearson Chi-Square and Kruskal–Wallis were performed for
ategorical  and continuous univariate analysis, respectively.
orrelation between psychopathological and HRQL scores was
erformed  according to Spearman’s correlation. Multivariate
nalysis was  performed according to stepwise forward ordi-
al  logistic regression. The signiﬁcance threshold was  ﬁxed at
 = 0.05. The power corresponding to sample size was  calcu-
ated  as the accumulated probability of the standard normal
istribution of the next percentile. SPSS, version 20 (SPSS Inc.,
hicago,  IL) was  used to conduct all the analysis.
Hypothesizing that subthreshold depression can impact
egatively on HRQL, we made a careful investigation of depres-
ive  symptoms. Therefore, we  made a ROC curve analysis
f  best cutoff value for BDI score capable of distinguishing
he two lower percentiles in WHOQOL-BREF overall HRQL. We
lso performed a detailed analysis of BDI items in order toALT, alanine aminotransferase.
a Mean ± standard deviation.
investigate if there were some items with stronger association
to  HRQL.
Ethical  issues
This study was  previously approved by the Research Ethical
Committee of the Federal University of Minas Gerais (number
560/08)  and written informed consent was obtained from all
subjects.
Results
Eighty-eight HCV patients were invited for an eligibility inter-
view.  Seven patients did not enter the study. Three of them
refused  to participate, and four had Mini Mental Status
Examination suggestive of cognitive impairment. Finally, 81
patients  were enrolled in the study. Comparing the 81 enrolled
patients  with the seven that did not enter the study, there
was  no signiﬁcant statistical difference related to: gender
(p  = 0.705), age (p = 0.527), ethnicity (p = 0.135), years of educa-
tion  (p = 0.204), years since HCV diagnosis (p = 0.264) and viral
genotype  (p = 0.724). Married status or stable relationship was
less  common in non-enrolled patients (p = 0.015), which also
presented  more inﬂammatory activity (p = 0.038) and ﬁbrosis
(p  < 0.001) at liver biopsy.Sociodemographic, clinical features and laboratory data
of  the studied sample are presented in Table 1. There
was a similar proportion of male and female, and the
mean  age was 43 years old. Non-white individuals were
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Table 2 – Correlation between sociodemographic, epidemiological, clinical features and health related quality of life
measures of 81 patients with chronic hepatitis C virus infection.
Physical Psychological Social Environment Overall
Agea 0.284 0.916 0.347 0.070 0.069
Genderb 0.358 0.305 0.142 0.489 0.891
Years of educationa 0.364 0.699 0.119 0.138 0.394
Ethnics (non-white)b 0.298 0.360 0.549 0.036 0.770
Marital status (married)b 0.004 0.016 0.905 0.380 0.125
Currently employedb 0.711 0.627 0.789 0.165 0.561
Comorbidityb 0.075 0.577 0.966 0.238 0.190
Intravenous drug useb 0.089 0.192 0.073 0.890 0.399
Tatoo or piercingb 0.447 0.216 0.063 0.311 0.482
Ever being in prisonb 0.347 0.153 0.037 0.567 0.751
Ever living in streetb 0.532 0.543 0.530 0.575 0.672
Illicit drug useb 0.263 0.012 0.016 0.451 0.813
Tobacco useb 0.645 0.080 0.559 0.631 0.656
Alcohool useb 0.930 0.567 0.129 0.358 0.939
Years since HCV diagnosisb 0.544 0.317 0.216 0.329 0.018
Viral genotype 1b 0.916 0.863 0.168 0.034 0.462
IFN current useb 0.055 0.819 0.490 0.913 0.139
METAVIR A ≥ 2b 0.897 0.910 0.923 0.812 0.451
METAVIR F ≥ 2b 0.336 0.890 0.604 0.874 0.686
ALT (IU/L)a 0.600 0.306 0.516 0.605 0.789
IFN, interferon-alpha; ALT, alanine aminotransferase.
a Kruskal–Wallis.
b Pearson Chi-Square.
Bold  p ≤ 0.05.
predominant (54.0%) and the mean education was  eight years.
About  half of the subjects declared to be married and only
14%  declared to live alone. Less than half of the patients
(43.0%) were  employed. Regarding interferon-alpha (IFN) use,
34  patients were  never exposed to it (naïve) 17 patients
were  currently using pegylated IFN at standard doses, and
30  patients had been previously treated with IFN. The two
main  HCV transmission modes were  blood transfusion (29.6%)
and  intravenous drug use (22.2%). The mean age since HCV
diagnosis  was  5.9 years, and viral genotype 1 was  predom-
inant  (77.8%). Mean alanine aminotransferase was  63.5 IU/L,
and  despite more  than half of patients presenting signiﬁ-
cant  hepatic ﬁbrosis, according to METAVIR classiﬁcation, only
7.4% had cirrhosis. Approximately half of patients had at least
one  clinical comorbidity, with hypertension being the most
common.
According  to DSM-IV criteria, 46 patients (56.8%) had cur-
rent  psychiatric disorder: 26 (32%) had depressive disorders,
18  (22.0%) anxiety disorders, 7 (9.0%) alcohol use disorders,
and  7 (9.0%) illicit drug use disorders. Among depressive dis-
orders,  there were  23 patients with major depression and three
with  distimia. The most common anxiety disorders were spe-
ciﬁc  phobia and generalized anxiety disorder, presented in
nine  and eight patients, respectively. Of note, 26 patients had
depressive  disorder diagnosis, but only nine of them were  cur-
rently using any antidepressant. Furthermore, only 27 (58.7%)
out  of 46 patients diagnosed with psychiatric disorder had
such  condition registered in their medical chart.
The median (range) HRQL scores were: 60.7 (17.9–100) on
physical  domain; 70.8 (8.3–95.8) on psychological domain; 58.3
(8.3–100)  on social domain; 56.3 (12.5–96.9) on environment
domain; 65.5 (0–100) on overall HRQL. In univariate analysis(Table  2), non-white subjects and viral genotype 1 were  asso-
ciated  with lower environment HRQL. Married individuals, or
with stable relationship, had higher scores both in physical
and  psychological domains. Previous history of incarceration
was  associated with lower scores in social domain. Previous
or  current illicit drug use was  associated to lower scores in
psychological and social domains. More years since diagnosis
of  HCV were  associated to lower scores in overall HRQL. Viral
genotype  1 was associated to lower scores in environment
domain. Patients with physical comorbidity seemed to have
lower  scores on physical domain, compared to those without
physical  comorbidity, but this difference was not statistically
signiﬁcant (p = 0.075).
Correlation between psychopathological factors, psychi-
atric  diagnosis and HRQL is presented in Table 3. We
found strong correlation between depression scores, accord-
ing  to BDI, and HRQL scores, according to WHOQOL-BREF:
physical (rho −0.593; p < 0.001), psychological (rho −0.691;
p  < 0.001), social (rho −0.401; p < 0.001), environment (rho
−0.489;  p < 0.001), overall (rho −0.588; p < 0.001).
According to BFI, fatigue was  found to be mild in 34 patients
(42.0%), moderate in 32 patients (39.5%) and severe in 15
patients  (18.5%). We also found strong correlation between
fatigue  scores, according to BFI, and HRQL scores: physical (rho
−0.644; p < 0.001), psychological (rho −0.624; p < 0.001), social
(rho  −0.336; p = 0.002), environment (rho −0.322; p = 0.003),
overall (rho −0.422; p < 0.001). Benzodiazepine current use
(n  = 13) was  associated with severe fatigue (p = 0.043), and its
use  did not differ according to gender (p = 0.249). A signiﬁ-
cant  correlation between depression scores, according to BDI,
and  fatigue scores, according to BFI, was  noticed (rho 0.646;
p  < 0.001).
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Table 3 – Correlation between psychopathological factors, psychiatric diagnosis and health related quality of life
measures of 81 patients with chronic hepatitis C virus infection.
Physical Psychological Social Environment Overall
Depressive disorders (n = 26)b <0.001 <0.001 0.007 0.063 <0.001
Anxiety disorders (n = 18)b 0.176 0.022 0.666 0.814 0.052
Alcohol use disorders (n = 7)b 0.734 0.499 0.620 0.638 0.959
Illicit drug use disorders (n = 7)b 0.359 0.718 0.005 0.443 0.912
Any psychiatric diagnosis <0.001 <0.001 0.384 0.465 0.036
Fatiguea <0.001 <0.001 0.027 0.021 0.012
Irritabilityb 0.120 0.070 0.114 0.391 0.206
MMSEa 0.332 0.363 0.080 0.393 0.283
Antidepressant use (n = 9)b 0.595 0.205 0.339 0.958 0.401
Benzodiazepine use (n = 13)b 0.015 0.026 0.384 0.069 0.050
BDIa <0.001 <0.001 0.002 <0.001 <0.001
HAD-Da <0.001 <0.001 0.002 0.003 <0.001
HAM-Da <0.001 <0.001 0.003 0.003 <0.001
HAD-Aa <0.001 <0.001 0.213 0.285 0.001
HAM-Aa <0.001 <0.001 0.001 0.010 <0.001
MMES, Mini Mental Status Examination; BDI, beck depression inventory; HAD-D, Hospital Anxiety and Depression Scale, depression subscale;
HAM-D, Hamilton Depression Scale; HAD-A, Hospital Anxiety and Depression Scale, anxiety subscale; HAM-A, Hamilton Anxiety Scale.
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BDI analysis revealed some interesting data. Its individual
tem  analysis showed that irritability (item 11) was  one of the
wo  most important items associated to lower HRQL scores
n  physical, psychological domains and on overall HRQL. BDI
atigue,  according to item 17, was  associated with poorer HRQL
n  physical (p = 0.001), psychological (p = 0.030) domain and
verall  HRQL (p = 0.003) but neither with social (p = 0.328) nor
nvironment  (p = 0.207) domains. Best BDI cutoff score to pre-
ict  worse overall HRQL was  16 points.
HRQL determinants, according to ordinal, stepwise, for-
ard,  multivariate analysis, are shown in Table 4. The
ower  corresponding to sample size was  calculated consid-
ring  depressive disorders and overall HRQL: 1  ˇ = 0.826; i.e.,
ower  = 82.6%. It means 17.4% chance of type II error when
onsidering association between depression and HRQL.
iscussione  found that depressive disorders, fatigue and non-married
tatus  were  independently associated with poorer HRQL in
CV  patients. To our knowledge this is the ﬁrst study to assess
RQL  in HCV patients using WHOQOL-BREF that combined
Table 4 – Health related quality of life determinants – ordinal, s
chronic hepatitis C virus infection.
Physical Psychologi
Depressive disorders p-value 0.012 0.001 
Odds ratio (conﬁdence interval) 3.79  6.04 
(1.33–10.76) (2.00–18.24
Fatigue p-value <0.001 0.002
Odds ratio (conﬁdence interval) 1.35  1.32
(1.14–1.59) (1.11–1.56)
Marital status (married) p-value 0.009
Odds ratio (conﬁdence interval) 0.31
(0.13–0.74)psychiatric structured interview and careful psychopatholo-
gical evaluation, including depression, anxiety and fatigue
instruments.
One  previous Brazilian HRQL study that performed psy-
chiatric  structured interview in HCV patients used SF-36 and
had  several exclusion criteria, such as IFN use, hypertension,
diabetes and hypothyroidism, limiting its external validity.26
This study found lower frequency of mood (18.9%) and anxiety
disorders  (15.6%), possibly reﬂecting more  stringent inclusion
criteria.
Elevated  frequency of depressive disorders in HCV patients
found  in our study is in accordance with the literature that
reports  higher rate than those found in other chronic infec-
tious  diseases like chronic hepatitis B.27 Furthermore, the
literature  shows that HRQL seems to be worse in HCV patients
when  compared to chronic hepatitis B patients.28 The high
rate  of unreported psychiatric diagnosis in charts and the low
percentage  of antidepressants use in the studied patients with
depressive  disorder highlight the need for improvement of
psychiatric  diagnosis and treatment in infectious disease ref-
erence centers. Another Brazilian study also found elevated
frequency (84.6%) of unrecognized mental disorders in HCV
patients  followed at a university-based clinic.29 Our result
tepwise forward, multivariate analysis of 81 patients with
cal Social Environment Overall
0.001 0.009 <0.001
4.29 3.16 7.52
) (1.76–10.44) (1.33–7.53) (2.94–19.21)
i s . 2 0
r
1
1
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endorses the importance of depression diagnosis and treat-
ment  among HCV patients.
More than half of the patients showed moderate to severe
fatigue  according to BFI, similar to chronic fatigue rates in
HCV  patients reported in other studies.30,31 One previous
study with HCV–HIV co-infected patients showed that self-
reported  fatigue was  associated with impairment in physical,
psychological and social HRQL domains, and was  a stronger
predictor of worse HRQL than depression.6 Two previous stud-
ies,  not speciﬁcally with HCV patients, evaluated temporal
relations between fatigue and depression, and found that each
one  might act as independent risk factors for each other.32
The cross-sectional nature of our study did not allow for an
explanation  of causality between depression and fatigue, but
endorses their relevance in predicting HRQL in HCV patients,
notably  in physical and psychological domains. Effective ther-
apeutic interventions to reduce the burden of fatigue are
desirable  in this context.
Being  married was  associated with better HRQL, also
shown in previous studies with HCV patients.6,33 One of these
reports  also found association between nonmarried status and
impairment  in social HRQL, but not in physical or psycholog-
ical  domains.6 Living alone did not interfere in HRQL scores.
The  low frequency of patients with advanced liver disease in
our sample could explain, at least in part, the lack of inﬂuence
of  living alone on HRQL.
Gender  did not interfere signiﬁcantly in any HRQL domain,
or  overall HRQL, in contrast to previous studies that showed
lower  scores of HRQL in female individuals.26,34 Age also did
not  inﬂuence signiﬁcantly HRQL. Age interference in HRQL of
HCV  patients is controversial, with some studies showing neg-
ative impact of age,34,35 while others no signiﬁcant inﬂuence.31
Our studied sample showed similar scores of HRQL in
physical,  psychological and environment domains, but lower
scores  in social domain when compared to the Brazil-
ian  general population WHOQOL-BREF normative data. The
underrepresentation of lower socioeconomic classes in nor-
mative  data, with consequent higher scores of HRQL, could
explain,  at least in part, the difference in social domain
scores.11
Our study had some clear limitations. Only 17 patients
(21.0%) were  using IFN during the study evaluation. This num-
ber  may  be too small in order to investigate IFN impact on
HRQL.  Economic aspects like monthly income, that could pos-
sibly have some inﬂuence on HRQL, were  not investigated.
In  conclusion, WHOQOL-BREF proved to be a useful instru-
ment  to assess HRQL in HCV Brazilian patients with good
ability  to distinguish patients with and without emotional
distress or other unfavorable determinants. Depression and
fatigue  scales, as BDI and BFI, could also be used as basic
easy-to-use measures of HCV patients’ well-being in clinical
settings.  The proper diagnosis and management of depression
and  fatigue in HCV patients could improve health assistance
and  warrant better patient-oriented outcomes, including
HRQL.  Future longitudinal studies with larger samples may
be  useful to better deﬁne the issue of causality or reverse
causality between depression and fatigue in HCV patients,
moreover to determine whether therapeutic strategies for
these  clinical problems can mitigate the associated HRQL
burden.
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